Katarzyna Urbanska
Philadelphia, Pennsylvania, United States
Dr. Katarzyna Urbanska is a highly accomplished professional with a strong background in Biochemistry and Molecular Biology.
She obtained her Ph.D. in Biochemistry and Molecular Biology from Uniwersytet Jagielloński w Krakowie and continued her studies at Temple University School of Medicine.
With an impressive career trajectory, Dr. Urbanska has held key positions in renowned organizations, showcasing her expertise and leadership skills.
Currently, she serves as the Director of Business Development in the Search & Evaluation department for Cell Therapy at Bristol Myers Squibb.
Prior to this role, she contributed significantly as the Director and Translational Medicine Team Lead in Immuno-Oncology at the same organization.
Her experience also includes serving as the Principal Scientist of Clinical Biomarker Immuno-Oncology at Bristol Myers Squibb.
Dr. Urbanska has diversified her knowledge by working in different pharmaceutical companies, including The Janssen Pharmaceutical Companies of Johnson & Johnson where she contributed to IO-Oncology Lung initiatives.
Before transitioning to industry roles, she honed her research skills as a Postdoctoral Research Associate at the University of Pennsylvania School of Medicine.
During her academic journey, she was a Ph.D. candidate at Temple University, emphasizing her commitment to continuous learning and growth.
Dr. Urbanska's career highlights her proficiency in business development, clinical biomarker research, and immuno-oncology, making her a valuable asset in the pharmaceutical and biotechnology sectors.
